No effect of cholesterol reduction on AD measures


A number of early reports suggested that the risk of AD was reduced in patients taking an HMG CoA reductase inhibitor (statin) (Wolozin et al. Arch Neurol 2000; 57: 1439-1443, free full text at; Rockwood et al. Arch Neurol 2002; 59: 223-227, free full text at

It takes 30 seconds

Recommend to a Colleague

Related Posts

Go back to home page